NEW YORK (AP) — Armed with hundreds of thousands of dollars from Newman’s Own Foundation and Ozempic creator Novo Nordisk, young Native Americans are leading the fight against persistently high rates of food insecurity in tribal communities. In a rare example of agency for a beneficiary community, 21 emerging Indigenous leaders recently crafted selection criteria,…
Costco to sell weight loss drugs Costco now selling weight loss drugs Ozempic, Wegovy at a discount 03:19 Costco customers can now buy Ozempic and Wegovy at the discount chain’s drugstores. Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and Wegovy are available at Costco pharmacies across the…
If you’re holding Novo Nordisk stock or considering jumping in, you’ve probably watched its recent moves with more than a little curiosity. Novo Nordisk may not be a household name on every street, but within the investing world it turns heads, thanks to a long-term run that’s seen plenty of growth balanced by some eye-catching…
By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics’ newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining traction. Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight management therapy available in China after Novo…
Novo Nordisk A/S (NYSE:NVO) presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025. The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy (semaglutide) 2.4 mg compared with Eli Lilly and Co.’s (NYSE:LLY) tirzepatide treatment in people with…
If you’re eyeing Novo Nordisk stock right now, you’re not alone. Investors have been left scratching their heads as to what comes next, after several twists in the company’s share price. In the past week, shares in Novo Nordisk slipped by 0.5%, following a stronger run over the last month with a climb of 6.9%….
00:02 Speaker A Now, time for some of today’s trending tickers. We are watching Synopsys, Novo Nordisk and Chewy. 00:09 Speaker A First up is Synopsys, the chip design software maker plunging after warning that US export restrictions are contributing to a slowdown in China. That’s the largest market for semiconductors. 00:23 Speaker A The…
Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it is cutting 9,000 jobs, or 11% of its workforce, amid increased competition for obesity medications. The company said it will cut about 5,000 jobs in Denmark, although it didn’t disclose where the remaining 4,000 reductions will be located. Novo Nordisk also makes…
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss drug trial results disappointed investors, overshadowing an otherwise strong quarterly earnings report and guidance increase. The pharmaceutical company announced late-stage trial data for its oral weight-loss pill, orforglipron, which showed an average weight loss of 12.4%. This…
Despite a steep 65% drop from its all-time high of 145.99 a share in the prior 12 months, Novo Nordisk remains one of the most operationally sound businesses on the planet. As an investor, you are getting exposure to the booming GLP-1 drug market and the stable, cash-rich insulin and diabetes care business, serving a…